Evoked Potentials Score Predicts Disability in Clinically Isolated Syndrome
October 14th 2019A composite score of a number of measurements of evoked potentials may be able to predict sustained accumulation of disability in patients with clinically isolated syndrome, which could provide clinicians insight into early disease.
Investigational Migraine Preventive ALD1910 Doses First Phase 1 Patient
October 14th 2019Alder Biopharmaceuticals announced the dosing of the first patient with ALD1910, its investigational monoclonal antibody that inhibits PACAP to prevent migraine. The study is aiming to enroll 100 individuals with results in mid-to-late 2020.
Lasmiditan Approved for Acute Migraine Treatment in Adults
October 11th 2019Eli Lilly’s lasmiditan (Reyvow) tablets are the first member of the ditan class approved for use in adults with migraine with or without aura, offering patients who have an inadequate response to other therapies a new acute treatment option.
Gait Speed Is a Relevant Marker of Functional Decline, Aging at Midlife
October 11th 2019The findings have implications for ongoing early intervention research in Alzheimer disease and dementia since significant functional and neurocognitive declines were evident in middle age adults based on gait speed assessments.
Reena Mehra, MD, MS: Importance of Screening for Obstructive Sleep Apnea
October 11th 2019The director of the Sleep Disorders Research Program at Cleveland Clinic Lerner College of Medicine discussed the importance of identifying and diagnosing obstructive sleep apnea as a prevention for a number of its consequential risk factors.
Nancy Chiaravalloti, PhD: Varying Benefits of Cognitive Rehab in MS and TBI
October 11th 2019The director of Centers for Neuropsychology and Neuroscience Research, and Traumatic Brain Injury Research at Kessler Foundation shared her perspective on the varying benefits different patient groups derive through strategy training for cognitive rehabilitation.
Sex-Specific Parameters May Improve MCI Diagnostic Errors
October 10th 2019The study unearthed a 20% diagnostic error rate with non-sex-specific parameters—10% false negatives in women and 10% false positives in men—which the authors found may be eliminated with gender-specific norms and cut scores.
Reena Mehra, MD, MS: Early Diagnosis of OSA
October 10th 2019The director of the Sleep Disorders Research Program at Cleveland Clinic Lerner College of Medicine discussed the importance of identifying and diagnosing obstructive sleep apnea as a prevention for a number of its consequential risk factors.
Tecfidera Generic Granted Tentative FDA Approval as Patent Assault Continues
October 9th 2019The latest generic entry comes on the heels of a new report from ICER, which published a list of prescription drugs that had substantial price increases in 2017 and 2018 without what they consider to be new supporting evidence.
MT1621 Substrate Enhancement Therapy Successful in Rare TK2 Deficiency Syndrome
October 9th 2019The impact MT1621 had on survival probably for those treated in comparison to the natural history of the often-fatal disorder was highly significant, with all patients remaining alive as of October.
Nancy Chiaravalloti, PhD: Strategy Training in Cognitive Rehabilitation
October 8th 2019The director of Centers for Neuropsychology and Neuroscience Research, and Traumatic Brain Injury Research at Kessler Foundation discussed the use of strategy training in the cognitive rehabilitation of patients with MS and TBI.
Edasalonexent Slows DMD Progression in Phase 2 Trial
October 7th 2019Treatment with the Catabasis Pharmaceuticals small molecule oral NF-kB inhibitor resulted in improvements in the 10-meter walk/run scores, time-to-stand scores, and 4-stair climb scores in 31 steroid-naïve boys with DMD aged 4 to 7 years.
Investigational Limb-Girdle Muscular Dystrophy Treatment Shows Promise at 9 Months
October 5th 2019New 9-month data suggest that Sarepta Therapeutics’ investigational limb-girdle muscular dystrophy type 2E treatment, SRP-9003, is linked to improved functional measures and reduction in creatine kinase.
Bernard Baumel, MD: Evaluating Stem Cells in Alzheimer Disease
October 4th 2019Bernard Baumel, MD, and colleagues at the University of Miami have recently launched a clinical trial to examine the safety and efficacy of multiple doses of human mesenchymal stem cells in patients with Alzheimer disease.
Marie D'hooghe, MD, PhD: Pregnancy Plans for Patients With MS
October 4th 2019The neurologist at the National MS Center and University Hospital, in Brussels, discussed the clinician mindset when treating women with MS who plan to get pregnant, and how patients using assistive reproductive treatments should be approached.
Acthar Gel Shows Top-Line Success in MS Relapse Registry
October 3rd 2019Mallinckrodt’s repository corticotropin injection (Acthar Gel) showed statistically significant results for every efficacy end point assessed, including the primary end point. Data will be shared at an upcoming medical meeting.
Upsher-Smith Launches Sumatriptan Nasal Spray for Acute Migraine Treatment
October 2nd 2019Originally approved by the FDA in January, sumatriptan nasal spray was acquired by Upsher-Smith in a territory rights agreement with Dr. Reddy’s Laboratories in June, as well as its 3-mg injection formulation (Zembrace SymTouch).